c-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic Cascade

Eitemau Tebyg

• c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression
  gan: Cantrell, Michael A., et al.
  Cyhoeddwyd: (2015)
• A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib
  gan: Ebelt, Nancy D., et al.
  Cyhoeddwyd: (2017)
• Mixed Lineage Kinase–c-Jun N-Terminal Kinase Axis: A Potential Therapeutic Target in Cancer
  gan: Rana, Ajay, et al.
  Cyhoeddwyd: (2013)
• c-Jun N-terminal Kinase 2 Regulates Multiple Receptor Tyrosine Kinase Pathways in Mouse Mammary Tumor Growth and Metastasis
  gan: Nasrazadani, Azadeh, et al.
  Cyhoeddwyd: (2011)
• c-Jun N-terminal Kinase 2 (JNK2) Enhances Cell Migration through Epidermal Growth Factor Substrate 8 (EPS8)
  gan: Mitra, Shreya, et al.
  Cyhoeddwyd: (2011)